Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 438.32B | 442.78B | 431.20B | 388.36B | 328.04B |
Gross Profit | 82.64B | 81.28B | 85.25B | 78.76B | 60.31B |
EBITDA | 40.59B | 40.95B | 50.88B | 48.52B | 37.75B |
Net Income | 14.90B | 15.82B | 27.21B | 22.55B | 17.09B |
Balance Sheet | |||||
Total Assets | 463.11B | 476.53B | 446.84B | 434.19B | 426.63B |
Cash, Cash Equivalents and Short-Term Investments | 47.43B | 46.64B | 47.75B | 54.87B | 69.81B |
Total Debt | 98.97B | 101.14B | 84.54B | 90.86B | 124.85B |
Total Liabilities | 228.09B | 250.12B | 255.80B | 273.27B | 309.91B |
Stockholders Equity | 225.54B | 217.19B | 182.83B | 153.41B | 110.68B |
Cash Flow | |||||
Free Cash Flow | 26.80B | 15.25B | 12.29B | 14.95B | 9.58B |
Operating Cash Flow | 43.85B | 39.86B | 23.91B | 24.25B | 20.83B |
Investing Cash Flow | -34.13B | -23.50B | -13.52B | -10.87B | -6.28B |
Financing Cash Flow | -9.10B | -15.03B | -20.18B | -32.71B | 1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥120.30B | 10.17 | 3.58% | 1.71% | -11.98% | ||
78 Outperform | €180.19B | 7.46 | 10.75% | 2.92% | -0.17% | 72.81% | |
77 Outperform | ¥220.66B | 8.53 | 3.70% | -1.35% | 21.33% | ||
77 Outperform | ¥208.38B | 7.64 | 2.69% | 0.49% | 27.98% | ||
70 Outperform | ¥205.20B | 31.51 | 1.56% | -4.23% | -28.48% | ||
67 Neutral | ¥218.71B | 32.86 | 4.53% | -2.24% | -43.32% | ||
61 Neutral | $17.23B | 11.50 | -5.97% | 3.09% | 1.49% | -16.00% |